A predictive, preventive, and personalized medicine (3PM)-guided clinical decision framework for interpreting routinely used tumor biomarkers is developed, shifting routine biomarker use from reactive testing and diagnostic escalation toward context-corrected interpretation, prevention of low-value investigations, and...
P. Kubatka, Ludmila Filkova, I. Slaninová et al.· The EPMA Journal· 0 citations
Overall survival varies significantly across primary sites with most favorable outcomes in breast cancer patients irradiated with SRS/FSRT, with most favorable outcomes in breast cancer patients irradiated with SRS/FSRT.
L. Hnidakova, Andrea Pagacova, Sarka Kristkova et al.· Medicina· 0 citations
This narrative educational review aims to provide a comprehensive overview of recent advances in the understanding of ovarian cancer pathogenesis, the molecular mechanisms driving tumor progression, and the multifaceted role of the immune system in disease development and therapeutic response.
B. Vavrušáková, R. Bartošová, M. Hendrych et al.· Discover Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.